Urinary tract infection (UTI) is one of the most prevalent infections in humans. In ≥80% of cases, the etiologic agents are strains of uropathogenic Escherichia coli (UPEC), which commonly reside in the gastrointestinal tract. Lactobacilli have been shown to prevent UTI reoccurrence by restoring the urogenital microbiota when administered vaginally or orally. The goal of this study was to determine if commercial probiotic Lactobacillus spp. reduce or clear UPEC in vitro. Results show that it is likely that lactobacilli may, in addition to restoring a healthy urogenital microbiota through acidification of their environment, also displace adhering UPEC and cause a reduction of infection.
INTRODUCTION
The urinary tract is constantly challenged by microbial invasion (Ali et al. 2009 ). This results in urinary tract infection (UTI) being one of the most prevalent infections in humans. The lifetime risk for acquiring a symptomatic UTI is about 50% in women and 12% in men, with a rate of recurrence after six months of about 40% (Sivick and Mobley 2010) . UTI incidence peaks in individuals in their early 20s and after age 85 (Foxman 1990) . If left untreated, bacteria may ascend the urinary tract and establish a secondary infection in the kidneys (acute pyelonephritis). In ≥80% of cases, the etiologic agents for UTIs are strains of uropathogenic Escherichia coli (UPEC), which commonly reside in the GI tract (Sivick and Mobley 2010) . It has been recognized that UPEC can invade host uroepithelial tissue, contributing significantly to the pathogenesis of UTIs by escaping a great number of antibiotics (Eto, Sundsbak and Mulvey 2006) . Internalized UPEC can persist in quiescence for long periods without causing clinical symptoms (Mulvey, Schilling and Hultgren 2001) .
For the treatment and prevention of UPEC-related UTIs including recurring infections, the use of low dose once daily or post-coital antimicrobials have been a cornerstone (Guay 2009 ). However, even with urine concentrations of antibiotics far exceeding minimal inhibitory concentrations, UPEC reservoirs in tissues were not eradicated effectively (Blango and Mulvey 2010) . Therefore, some alternative non-antimicrobial based therapeutic approaches such as probiotics that may inhibit bacterial adherence and colonization may be of benefit.
The use of probiotics and fermented milk products against UTI has previously been assessed (Kontiokari et al. 2003) . However, while there is evidence that lactobacilli have an effect on UTI, their mechanism of action has thus far not been elucidated, with most studies relying on circumstantial evidence (Bruce and Reid 1988; Saxelin, Pessi and Salminen 1995; Reid and Burton 2002) . In all, biosurfactants, bacteriocins, lactic acid and hydrogen peroxide from Lactobacillus sp. seem to be inhibitory for UPEC growth, while adversely affecting fimbrial structure and adhesion and upregulating immunogenic membrane proteins (Hagan and Mobley 2007; Cadieux et al. 2009 ).
The goal of this study was to assess the in vitro antimicrobial/bacteriostatic activity of selected commercial Lactobacillus strains, against UPEC.
MATERIALS AND METHODS

Organisms
Lactobacillus johnsonii strains NCC533 and NCC2917, L. rhamnosus NCC4007 and L. acidophilus NCC2463, provided by the Nestlé culture collection (Nestec Ltd., Lausanne, Switzerland). Uroseptic E. coli strain CFT073 (O6:K2:H1, ATCC700928) was isolated from the blood and urine of a woman with acute pyelonephritis (Mobley et al. 1990 ). The strain was purchased from the American Type Culture Collection (LGC Standards, Molsheim Cedex, France). The UPEC strain UTI89 (O18:K1:H7) was isolated from a patient with an acute cystitis (Mulvey, Schilling and Hultgren 2001) . The strain was kindly provided by Prof. Urs Jenal from the Biocenter of the University of Basel (Basel, Switzerland). For cell culture assays, the human bladder cancer cell line UM-UC-3 (ATCC CRL-1749) was purchased from the American Type Culture Collection (LGC Standards, Molsheim Cedex, France). Bacterial culture media and components were purchased from Oxoid (Basingstoke, UK) while cell culture media, cell culture components and chemicals were purchased from Sigma (Buchs, Switzerland) unless stated otherwise.
Coculture of UPEC and Lactobacillus spp.
All organisms were grown in fresh LAPT overnight at 37
• in 100 mL of fresh mMRS and grown statically for 24 h at 37
Then, cells were pelleted by centrifugation at 10 000 g (20 min, 4
• C) and the supernatant was collected. For one batch, the supernatant was adjusted to pH 7.0 using 1N NaOH while for another batch, the supernatant was kept at its native pH (4.0-4.4).
Supernatants (cell-free culture supernatants, CFCS) were filtersterilized (0.22 μm) and fortified using 20% 4× mMRS to avoid the effect of nutrient depletion when used to grow UPEC. This fortification minimally raised the pH of the supernatants to pH 4.7-5.5. In order to assess H 2 O 2 production of Lactobacillus spp. and its influence on UPEC growth, Lactobacillus spp. were grown overnight (37 • C) on LAPT. Next, cells were diluted to 1 × 10 5 cfu mL −1 in 100 mL of fresh LAPT and grown statically for 24 h at 37
• C. Then, cells were transferred to a sterile 500 mL culture flask and incubated at 37
• C for 2 h while shaking at 150 rpm. Cells were then pelleted by centrifugation at 4000 g (10 min, 4
• C), and the supernatant was collected. The supernatant was pH neutralized using 1N NaOH, filter-sterilized (0.22 μm) and fortified using 20% 4× LAPT to avoid the effect of nutrient depletion when used to grow UPEC. Concentrations of H 2 O 2 were measured before addition of UPEC and after 24 h using a Quantifix Peroxide 25 dipstick (Macherey-Nagel, Düren, Germany). All CFCS were stored at −20 • C until use.
UPEC growth in cell-free culture supernatants
Two hundred thirty micro litres of fortified CFCS was added to 96-well Greiner flat bottom microtitre plates (Sigma, Buchs, Switzerland) . Overnight cultures (37 • C) of UPEC were diluted to 1 × 10 7 cfu mL −1 in PBS (pH 7.0) before 20 μL of culture was added to the microtitre plates giving a final volume of 250 μL. Optical density measurements at 600 nm were taken every 15 min for 12 h while incubating at 37
• C on a BMG Labtech SpectroStar Omega (BMG LABTECH GmbH Ortenberg, Germany). Prior to each measurement, the plate was shaken for 10 s.
Acid production by Lactobacillus spp.
Overnight cultures of Lactobacillus spp. were diluted to 1 × 10 8 cfu mL −1 in sterile LAPT and added to fresh LAPT to give a final volume of 10 mL. In order to assess the production of volatile organic acids by Lactobacillus spp., 1 mL aliquots of culture was taken at inoculation (T0), after 6 h (T6) and after 24 h (T24) growth at 37 • C and filtered using a 0.22 μm syringe filter.
The filtrate was run on an HPLC Agilent series 1100 HPLC (Agilent, Basel, Switzerland) using a Cation H+ pre-column (BioRad, Cressier, Switzerland) and Aminex HP×-87H column (BioRad) at a flow rate of 0.6 ml min −1 (25 min, 35
• C) and an isocratic mobile phase of 5 mM H 2 SO 4 . Citric acid, lactic acid, acetic acid, succinic acid, pyruvic acid, propionic acid and butyric acid were detected by refractive index and UV (210 nm) spectrometry.
Cell culture adherence-invasion assay
The human bladder cancer cell line UM-UC-3 (ATCC CRL-1749) was cultured to confluence in 6-well cell culture plates (Corning) using Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum (FBS) at 37 % of adhesive UPEC = Number of invasive cfu Number of adherent cfu × 100.
Bacterial invasion was measured using the gentamicin protection assay (Edwards and Massey 2011) . After the 2 h of infection, cells were incubated with 100 μg mL −1 gentamicin for 30 min. Cells were then washed 4× with PBS (without CaCl 2 or MgCl 2 ) and lysed using 1 × Trypsin-EDTA including 0.25% (v/v) Triton ×-100 and plated (10 −2 -10 −8 dilutions) onto NA to enumerate invasive UPEC. Colonies (after 24 h, 37
were identified as either UPEC or Lactobacillus spp. by Gram strain and microscopy:
% of invasive UPEC = Number of invasive cfu Number of adherent cfu × 100.
RESULTS AND DISCUSSION
Coculture of UPEC and Lactobacillus spp.
In this study, we assessed the in vitro antimicrobial activity of five Lactobacillus strains against UPEC. There is evidence that Lactobacillus GR-1 upregulates host antimicrobial factors (Kirjavainen et al. 2008) . However, other factors such as the acidic inhibition of growth, induction of stress in the outer membrane and modification of the environment to one that is less conducive to UPEC thriving seem equally plausible for this and other strains. In particular, the antimicrobial role of lactic acid produced by lactobacilli has been controversial in literature with hypothesis ranging from no role at all to lactic acid being an important factor (Fayol-Messaoudi et al. 2005; De Keersmaecker et al. 2006; Makras et al. 2006) . Previous data suggest that L. johnsonii NCC533 reduced the viability of UPEC through a combined activity of hydrogen peroxide and lactic acid. Plate counts of UPEC on NA (Fig. 1) showed that after 24 h L. johnsonii NCC533 and L. rhamnosus NCC4007 significantly reduced UPEC counts to below inoculum levels. There was a significant reduction of growth of E. coli UTI89 when comparing counts at 0 and 24 hof coculture as well as when comparing counts at 6 and 24 h in cocultures containing L. johnsonii NCC533 (P = 0.003 and 0.0001, respectively). For L. rhamnosus NCC4007, the reduction in counts was only significant when comparing 6 and 24 h of culture (P = 0.002). There also was a significant reduction of growth of E. coli CFT073 when comparing counts at 0and 24 h of culture as well as when comparing counts at 6 and 24 h of culture with L. johnsonii NCC533 (P = 0.004 and 0.0001, respectively). For L. rhamnosus NCC4007, the reduction in counts was only significant when comparing 6 and 24 h of culture (P = 0.002). In contrast to previous reports, the acidification of the coculture medium may be the primary factor that causes this reduction (Atassi and Servin 2010) . For other Lactobacillus species examined here, there was no significant effect on either UPEC strain. This may be due to various lactobacilli exerting differing activities on UPEC, which warrants more detailed characterizations of lactobacilli functions in the future. Similar has previously been described for lactobacilli protecting gut barrier functions from enterotoxigenic E. coli (Liu et al. 2015) .
UPEC growth in cell-free culture supernatants
The growth of UTI89 and CFT073 on CFCS was examined spectrophotometrically over a period of 12 h at A 600nm in order to assess what cell-free factors may influence a reduction of UPEC cell counts (Fig. 2) . Acidic cell-free culture supernatant (CFCS) (pH 4.7-5.5) from any Lactobacillus spp. completely inhibited the growth of both UPEC strains. When the CFCS was neutralized (pH7.0), both UPEC strains grew normally in CFCS of all Lactobacillus spp. even though the exponential phase was slightly shifted in time. Similar growth was detected in hydrogen peroxidecontaining CFCS. The acidic hydrogen peroxide-free CFCS of L. johnsonii NCC533, and the other strains tested showed complete inhibition of UPEC strains CFT073 and UTI89. However, H 2 O 2 -containing CFCS adjusted to pH 7.0 had no effect. Furthermore, indicator strips for hydrogen peroxide quantification showed a complete loss of H 2 O 2 (at concentrations produced by lactobacilli) over the time of the assay, presumably due to UPEC catalase activity. Other compounds that may be secreted by either L. johnsonii NCC533, L. johnsonii NCC2917, L. rhamnosus NCC4007 or L. acidophilus NCC2463 that may act in synergy with lactic acid as hypothesized by Niku-Paavola et al. (1999) also did not have an effect, as demonstrated in UPEC cultures with H 2 O 2 -free CFCS at pH7.0. HPLC analysis of acids showed that lactic acid production increased in Lactobacillus spp. cultures over a 24 h period, ranging from 0 to 0.1 g L −1 at inoculation to 4.7-6.4 g L −1 after 24 h (Table 1) . No other acids were detected in significant amounts. Besides a reduction of pH, possible mechanisms for the antimicrobial activity of lactic acid may be its function as a permeabilizer of Gram-negative bacterial outer membranes and its chelating properties (Alakomi et al. 2000) . Lactic acid may capture iron which is essential for UPEC growth, causing inhibition (Presser, Ratkowsky and Ross 1997) .
Cell culture adherence-invasion assay
Cell culture of the human bladder cancer cell line UM-UC-3 coinoculated with either UTI89 or CFT073 and Lactobacillus spp. showed large variations in adhesion and invasion properties between replicates (Fig. 3) . When comparing the% adhesion of UTI89 to UM-UC-3 cells to the percentage of adhesion of UTI89 to UM-UC-3 cells when coinoculated with Lactobacillus spp., there was a general trend of reduced adhesion of UTI89 when coinoculated with either L. johnsonii NCC533, L. johnsonii NCC2917 or L. rhamnosus NCC4007 while adhesion tended to increase when UPEC strains were coincubated with L. acidophilus NCC2463. This effect is possibly due to L. acidophilus NCC2463 not being able to displace UPEC from the surface of UM-UC-3 cells. For E. coli CFT073, a trend for reduction of adhesion was observed for L. johnsonii NCC533 and L. johnsonii NCC2917 only. In the absence of Lactobacillus strains, only 2% of adherent E. coli UTI89
were invasive while 17% of adherent E. coli CFT073 were invasive (100% = 1 × 10 8 cfu mL −1 ). While there was a general trend for reduction of invasiveness for both UTI 89 and CFT073 coinoculated with Lactobacillus spp., results did not reach significance. An additional mechanism for UPEC inhibition may be the direct displacement of UPEC adhering to uroepithelial cells by lactobacilli. This would also cause a reduction in adherence and infection (Velraeds et al. 1999 ). This possible mechanism was demonstrated in the uro-epithelial cell culture model coincubated with UPEC strains CFT073 and UTI89. Here, L. johnsonii NCC533, L. johnsonii NCC2917 and L. rhamnosus NCC4007 reduced the adhesion of both UPEC strains, even though the results were not significant and assay variation in this study were too great to make definite assumptions.
CONCLUSION
In conclusion, with increasing rates of antimicrobial resistance in important pathogens, there is a growing interest in the targeted application of lactobacilli against pathogens. UTI in particular has been a promising lead for Lactobacillus spp. therapy as it is mainly caused by one organism, UPEC. While cranberry juice has been a popular home-remedy, the most promising lead towards the treatment of UTI is the installation of Lactobacillus into the vagina to form a barrier from infection (Cadieux et al. 2009; Guay 2009 ). Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 have been the most promising candidates for this (Reid and Burton 2002) . Commercial probiotic Lactobacillus spp., such as the ones examined here, may also provide protection from UTI not necessarily by direct killing of UPEC, but rather through growth inhibition and direct displacement of UPEC cells. A membrane permeabilization caused by produced lactic acid as described by Alakomi et al. (2000) may also be possible. Further in vitro studies followed by in vivo trials are needed for confirmation.
